← Cerebras Systems Inc. Class A Common Stock overview
Cerebras Systems Inc. Class A Common StockCBRS

Why is Cerebras Systems Inc. Class A Common Stock (CBRS) moving?

Q3 2026
▼2▲1

Cerebras Grows Fast but Margins, Probe, Competition Bite

  • Explosive Revenue and Backlog Growth Revenue jumped 92% to $193.4 million, cloud revenue surged 287%, and backlog hit $25.4 billion, mostly from a $20 billion OpenAI deal. This shows demand is booming and future sales are locked in.

    This is the core positive force driving investor optimism and the stock's potential upside.

  • Margin Pressure and Revenue Miss Hardware sales fell 23%, causing a revenue miss, and gross margin guidance dropped to 38–41%. This means profits are shrinking, and the company is not selling as much of its main product as expected.

    This is a key negative factor that directly weighs on profitability and investor confidence.

  • Securities-Fraud Probe and Competitive Threats A securities-fraud probe tied to the IPO adds uncertainty, while Nvidia and Microsoft competition intensifies. A SemiAnalysis report claims Nvidia, not Cerebras, powers OpenAI's fastest tier, undercutting its speed advantage.

    These legal and competitive risks could damage reputation and market position, pressuring the stock.

  • Expansion and Partnerships vs. Widening Losses New partnerships with AMD and CrowdStrike, plus customers like Figma and GSK, broaden its base. Finland expansion boosts capacity but widens losses, pressuring near-term profits.

    This shows both growth initiatives and the cost of expansion, balancing positive and negative impacts.

September 2026
▲2▼1

Cerebras' OpenAI Backlog Grows, but Nvidia Chip Report Hits Shares

  • OpenAI backlog and raised 2026 guidance underpin growth Cerebras holds $25.4 billion in signed but undelivered work, mostly from OpenAI's 750 MW commitment, and raised 2026 core revenue guidance to $880–$890 million. Q2 core revenue rose 103% to $209.9 million. This supports the long-term growth story, though only about 22% of the backlog converts in the next two years.

    It is the core positive force behind the stock's long-term value and was updated this period.

  • Inference push and new customers broaden demand Cerebras is targeting 20x throughput gains and 5x speedup with AMD Helios racks, and added customers like Cognition, Figma, Block, GSK and CrowdStrike. Six deals worth over $30 million each were signed in Q2. This shows its fast-inference technology is winning business beyond OpenAI, supporting future revenue.

    It shows Cerebras is diversifying its customer base and advancing its technology, a key growth driver.

  • Report says Nvidia, not Cerebras, powers OpenAI's fastest tier A SemiAnalysis report said OpenAI's GPT-6.1 Sol Ultrafast tier runs on Nvidia GPUs, not Cerebras chips. Shares fell 7%. This challenges Cerebras' key selling point—speed at low batch sizes—and raises doubts about its role in OpenAI's future infrastructure, hurting near-term confidence.

    It is a direct competitive threat that questions the durability of Cerebras' OpenAI relationship.

  • Finland data center expands capacity but losses persist Cerebras announced a 165 MW AI data center in Finland, with 600 MW secured for 2027. But core operating losses are widening, with Q3 guidance at negative 25–23% margin. The heavy spending to build capacity supports future growth but pressures near-term profits and cash flow.

    It highlights the trade-off between capacity expansion and ongoing losses, a key tension for the stock.

Latest
▲2▼1

Cerebras' OpenAI Backlog Grows, but Nvidia Chip Report Hits Shares

  • OpenAI backlog and raised 2026 guidance underpin growth Cerebras holds $25.4 billion in signed but undelivered work, mostly from OpenAI's 750 MW commitment, and raised 2026 core revenue guidance to $880–$890 million. Q2 core revenue rose 103% to $209.9 million. This supports the long-term growth story, though only about 22% of the backlog converts in the next two years.

    It is the core positive force behind the stock's long-term value and was updated this period.

  • Inference push and new customers broaden demand Cerebras is targeting 20x throughput gains and 5x speedup with AMD Helios racks, and added customers like Cognition, Figma, Block, GSK and CrowdStrike. Six deals worth over $30 million each were signed in Q2. This shows its fast-inference technology is winning business beyond OpenAI, supporting future revenue.

    It shows Cerebras is diversifying its customer base and advancing its technology, a key growth driver.

  • Report says Nvidia, not Cerebras, powers OpenAI's fastest tier A SemiAnalysis report said OpenAI's GPT-6.1 Sol Ultrafast tier runs on Nvidia GPUs, not Cerebras chips. Shares fell 7%. This challenges Cerebras' key selling point—speed at low batch sizes—and raises doubts about its role in OpenAI's future infrastructure, hurting near-term confidence.

    It is a direct competitive threat that questions the durability of Cerebras' OpenAI relationship.

  • Finland data center expands capacity but losses persist Cerebras announced a 165 MW AI data center in Finland, with 600 MW secured for 2027. But core operating losses are widening, with Q3 guidance at negative 25–23% margin. The heavy spending to build capacity supports future growth but pressures near-term profits and cash flow.

    It highlights the trade-off between capacity expansion and ongoing losses, a key tension for the stock.

August 2026
▲2▼2

Cerebras Cloud Booms but Hardware Slump and Competition Weigh

  • Cloud Revenue Surge and Raised Guidance Cerebras's cloud business revenue jumped 287% to $127.7 million, prompting management to raise full-year guidance. This shows strong demand for its AI compute services and supports the bullish case for future growth.

    This is a key new positive development that drove optimism about Cerebras's cloud segment.

  • Massive Backlog and OpenAI Commitment A $25.4 billion backlog, including a multi-year OpenAI deal worth over $20 billion and a 750MW commitment, provides long-term revenue visibility. This reinforces confidence in Cerebras's growth trajectory despite near-term headwinds.

    This highlights the scale of committed demand that underpins the long-term bull case.

  • Hardware Sales Decline and Revenue Miss Hardware sales fell 23% to $54.1 million, causing Cerebras to miss overall revenue expectations and triggering double-digit stock drops. This raises concerns about execution and demand for its chip products.

    This is a major new negative factor that directly pressured the stock during the period.

  • Intensifying Competition from Nvidia and Microsoft Nvidia's dominant scale and $40 billion ACIE business, plus Microsoft's 88 new data centers, threaten Cerebras's ability to win business. This competitive pressure could limit future growth and market share.

    This is a new competitive threat that emerged as a key risk to Cerebras's outlook.

▲2▼2

Cerebras Expands Global Capacity as Earnings Miss and Nvidia Competition Weigh

  • Q2 revenue miss and hardware decline Cerebras reported Q2 revenue of $180.1 million, up 74% but below the $194.2 million analysts expected, and hardware sales fell to $54.1 million from $70.3 million a year earlier. The stock tumbled 14% as investors worried about execution and chip demand.

    This is the main negative force this period, explaining the sharp selloff and ongoing pressure on the stock.

  • Backlog and raised guidance support long-term story Despite the miss, Cerebras raised full-year core revenue guidance to $880–$890 million and reported a $25.4 billion backlog, anchored by a multi-year OpenAI deal worth over $20 billion. Analysts see 57% upside, with a consensus target of $291.64.

    This is the key positive counterweight, showing strong future demand and analyst confidence despite the recent selloff.

  • Global data center expansion secures capacity Cerebras signed a 165 MW AI data center deal in Finland and has secured over 600 MW of capacity for 2027. It also signed six deals worth over $30 million each in Q2, showing strong customer demand for its AI compute platform.

    This demonstrates tangible progress in building the infrastructure needed to meet demand, a key growth driver.

  • Intensifying competition from Nvidia and Microsoft Nvidia's blowout earnings and $40 billion ACIE business, plus Microsoft's 88 new data centers, highlight the fierce competition Cerebras faces. Nvidia's scale and ecosystem investments could make it harder for Cerebras to win business.

    This is a major competitive threat that could cap Cerebras's growth and weighs on investor sentiment.

▲4

Cerebras Rides OpenAI Ties and New CS-4 Chip to Fresh Gains

  • OpenAI exclusivity and 750MW commitment Wedbush tied Cerebras to OpenAI's new ultrafast GPT-5.6 mode as its exclusive compute backbone, with OpenAI committed to 750MW of capacity by 2028. That locks in huge future demand and sent the stock up 15%.

    This is the biggest new catalyst, directly linking Cerebras to a major customer and lifting the stock.

  • CS-4 system launch claims 30x speed Cerebras unveiled the CS-4 rack-scale system, claiming 30 times the speed of GPU-based solutions and 10 times better power efficiency. The new product strengthens its competitive edge in AI inference and supports long-term sales growth.

    The CS-4 launch is a major new product event that boosts Cerebras's technology leadership and future revenue potential.

  • Wafer supply secured and infrastructure expanded Wedbush noted Cerebras is expanding 2027 infrastructure and securing additional wafer supply for its wafer-scale processors. This helps address supply constraints and supports the company's ability to meet growing demand.

    This new detail on supply and expansion reduces a key risk and supports future revenue delivery.

  • Digi Power X $1.1B take-or-pay contract Digi Power X is building toward a $140 million+ annual run rate by 2027, anchored by a $1.1 billion take-or-pay contract with Cerebras for 40MW in Alabama. This shows strong contracted demand for Cerebras's capacity.

    This new contract detail provides concrete evidence of demand for Cerebras's infrastructure.

▲3▼1

Cerebras Cloud Surges, Hardware Slumps; Guidance Raised

  • Cloud revenue nearly quadruples, guidance raised Cerebras's cloud business, which rents out AI computing power, grew 287% to $127.7 million. Management raised full-year revenue and margin targets and said core revenue will more than triple in 2027. This growing, higher-margin business is the main reason to own the stock.

    The cloud surge and raised guidance are the core positive forces behind the stock's long-term story.

  • Hardware sales unexpectedly fall 23% Revenue from selling actual chip systems dropped 23% to $54.1 million, and overall revenue missed analyst estimates. The stock fell over 12% as investors worried Cerebras's chips may struggle to win business against Nvidia. This is the main counterweight to the cloud story.

    The hardware decline is the key negative that dragged the stock down and tests the AI growth narrative.

  • Ark Invest keeps buying, institutional interest grows Cathie Wood's Ark Invest bought another $13.1 million of Cerebras shares, after earlier purchases near the lows. A well-known fund stepping in signals confidence and can attract other buyers, supporting the stock price even after the post-earnings drop.

    Ark's continued buying is a fresh capital-flow signal that supports the stock.

  • Inference market projected to hit $1.3 trillion by 2032 Bloomberg Intelligence sees the AI inference market growing 32% a year to $1.3 trillion, double the training market. Cerebras's fast inference chips and partnerships with OpenAI and AMD position it to capture a slice of this huge, growing pie, supporting long-term demand.

    The massive market forecast underpins the long-term demand case for Cerebras's inference chips.

July 2026
▲2▼1

Cerebras Rallies on Growth, But Margin and Legal Risks Loom

  • Strong Revenue and Backlog Cerebras reported 92% revenue growth to $193.4 million and a backlog exceeding $20 billion, including a $20 billion OpenAI deal. This shows robust demand for its AI compute solutions.

    This highlights the core growth driver that boosted investor confidence during the period.

  • Analyst Optimism and Partnerships Analysts raised price targets (UBS $320, Morgan Stanley $273) citing 47% upside, while AMD and CrowdStrike partnerships and a sevenfold CS-3 production boost via Flex signaled expanding ecosystem and capacity.

    These developments reinforced the bullish narrative and attracted investor interest.

  • Margin Pressure and Legal Probe Gross margin is guided down to 38–41% from 47% due to renting back its own systems, and Pomerantz is investigating potential securities fraud tied to the IPO and Q1 loss, adding uncertainty.

    These risks tempered the rally and could weigh on future profitability and investor trust.

▲4

Cerebras Rallies on AMD and CrowdStrike Deals, Manufacturing Expansion

  • AMD Partnership for AI Inference Cerebras and AMD announced a technical partnership to combine AMD's Helios rackscale systems with Cerebras's wafer-scale chips for faster AI inference. This validates Cerebras's technology and opens new sales channels, pushing the stock up.

    This is a new, concrete partnership that directly boosts demand and credibility for Cerebras.

  • CrowdStrike Cybersecurity Partnership CrowdStrike will use Cerebras chips in its Falcon security platform, while Cerebras adopts CrowdStrike's AI for its own infrastructure. This expands Cerebras's customer base into cybersecurity, driving demand for its hardware and lifting the stock.

    A new partnership that diversifies Cerebras's customer base and demonstrates real-world adoption.

  • Manufacturing Expansion and European Data Centers Cerebras expanded its Flex partnership to boost CS-3 production sevenfold by 2026 and announced multi-billion-dollar European data centers targeting 200 MW by end-2027. These moves address supply constraints and signal future revenue growth, supporting the stock.

    These are new capacity expansions that directly address supply and growth prospects.

  • Analyst Optimism and Valuation Gap Wall Street sees 47% upside over the next year, and one estimate puts fair value at $415, far above the recent $208 price. This optimism, based on strong revenue growth and a $24.6 billion backlog, attracts buyers and pushes the stock up.

    Analyst targets and valuation gaps are key drivers of investor sentiment and price.

▲2▼1

Cerebras Surges on European Data Center and Manufacturing Expansion

  • European Data Center Expansion Cerebras announced a multi-billion-dollar plan to build its first European data centers in France and the Nordic region, targeting 200 megawatts by end-2027. This signals growing demand and future revenue, pushing the stock up nearly 7%.

    This is the main new event that drove the stock higher this period.

  • CS-3 Manufacturing Boost with Flex Cerebras expanded its partnership with Flex to increase CS-3 AI supercomputer production capacity sevenfold by 2026. This addresses supply constraints and supports future sales, lifting investor confidence and the stock price.

    This new manufacturing deal directly supports growth and was a key driver of the stock's rise.

  • Securities Fraud Investigation Pomerantz Law Firm is investigating Cerebras for potential securities fraud related to its IPO and Q1 loss. This legal risk could weigh on the stock by raising uncertainty and potential costs.

    This is a new negative development that provides a counterweight to the positive news.

▲3▼1

Analysts See Big Upside in Cerebras After Strong First Post-IPO Quarter

  • Analyst price target hikes Morgan Stanley, UBS, and Wedbush raised their price targets after Cerebras's first public quarter, with UBS at $320 and Morgan Stanley at $273. These upgrades signal confidence in future growth and can pull the stock up as investors follow analyst guidance.

    This is the main new event this period and directly boosts investor sentiment and the stock price.

  • Strong revenue growth and huge backlog Cerebras reported 92% revenue growth to $193.4 million and a backlog over $20 billion, including a $20 billion OpenAI deal. This shows strong demand for its AI chips, which supports the stock price by pointing to future sales.

    It highlights the fundamental demand driver that underpins the bullish analyst views.

  • Long-term upside potential One analyst sees 175% upside by 2028 if Cerebras hits $7.4 billion in revenue and trades at 15 times sales. This long-term projection gives investors a reason to look past current margin issues and can lift the stock.

    It provides a concrete bullish scenario that could attract investors despite near-term concerns.

  • Margin pressure remains a concern Cerebras guided full-year gross margin to 38-41%, down from 47% in Q1, due to renting back its own systems. This profitability worry is a real counterweight that could keep the stock from rising too fast.

    It is the main negative factor that balances the positive news and explains why the stock isn't higher.

Q2 2026
▼3▲1

Cerebras Plunges Below IPO Price on Margin Warning

  • Margin Guidance Disappoints Cerebras guided Q2 gross margin to 36-38% from 47% in Q1, and full-year operating margins of negative 28-32%. Investors fear profitability will lag rivals like Nvidia, pushing the stock down over 20% this period.

    This is the main new negative catalyst that drove the stock below its IPO price.

  • Stock Falls Below IPO Price CBRS dropped nearly 10% below its $185 IPO price, just five weeks after going public. The stock peaked above $386 but has lost over half its value, signaling that post-IPO euphoria has faded and valuation is contracting.

    This is a new milestone that shows the severity of the sell-off and its impact on investor sentiment.

  • Strong Q1 Revenue and OpenAI Deal Cerebras beat Q1 estimates with revenue up 94% to $193.4 million and raised full-year guidance. It also has a $20 billion multi-year OpenAI deal for 750 MW of AI compute, which underpins future growth despite current margin concerns.

    This is the fundamental positive that provides a counterweight to the negative price action.

  • Customer Concentration Risk Nearly three-quarters of sales come from two UAE clients, and the OpenAI deal dominates the backlog. This heavy reliance on a few customers makes future revenue volatile and worries investors about diversification.

    This is a key risk factor that explains why the market is skeptical despite strong revenue growth.

June 2026
▼3▲1

Cerebras Plunges Below IPO Price on Margin Warning

  • Margin Guidance Disappoints Cerebras guided Q2 gross margin to 36-38% from 47% in Q1, and full-year operating margins of negative 28-32%. Investors fear profitability will lag rivals like Nvidia, pushing the stock down over 20% this period.

    This is the main new negative catalyst that drove the stock below its IPO price.

  • Stock Falls Below IPO Price CBRS dropped nearly 10% below its $185 IPO price, just five weeks after going public. The stock peaked above $386 but has lost over half its value, signaling that post-IPO euphoria has faded and valuation is contracting.

    This is a new milestone that shows the severity of the sell-off and its impact on investor sentiment.

  • Strong Q1 Revenue and OpenAI Deal Cerebras beat Q1 estimates with revenue up 94% to $193.4 million and raised full-year guidance. It also has a $20 billion multi-year OpenAI deal for 750 MW of AI compute, which underpins future growth despite current margin concerns.

    This is the fundamental positive that provides a counterweight to the negative price action.

  • Customer Concentration Risk Nearly three-quarters of sales come from two UAE clients, and the OpenAI deal dominates the backlog. This heavy reliance on a few customers makes future revenue volatile and worries investors about diversification.

    This is a key risk factor that explains why the market is skeptical despite strong revenue growth.

▼3▲1

Cerebras Plunges Below IPO Price on Margin Warning

  • Margin Guidance Disappoints Cerebras guided Q2 gross margin to 36-38% from 47% in Q1, and full-year operating margins of negative 28-32%. Investors fear profitability will lag rivals like Nvidia, pushing the stock down over 20% this period.

    This is the main new negative catalyst that drove the stock below its IPO price.

  • Stock Falls Below IPO Price CBRS dropped nearly 10% below its $185 IPO price, just five weeks after going public. The stock peaked above $386 but has lost over half its value, signaling that post-IPO euphoria has faded and valuation is contracting.

    This is a new milestone that shows the severity of the sell-off and its impact on investor sentiment.

  • Strong Q1 Revenue and OpenAI Deal Cerebras beat Q1 estimates with revenue up 94% to $193.4 million and raised full-year guidance. It also has a $20 billion multi-year OpenAI deal for 750 MW of AI compute, which underpins future growth despite current margin concerns.

    This is the fundamental positive that provides a counterweight to the negative price action.

  • Customer Concentration Risk Nearly three-quarters of sales come from two UAE clients, and the OpenAI deal dominates the backlog. This heavy reliance on a few customers makes future revenue volatile and worries investors about diversification.

    This is a key risk factor that explains why the market is skeptical despite strong revenue growth.